Steven C. Gilman

Director at Scynexis · 2 reported transactions in 2 companies · latest report Jun 26, 2025

Their trades


ScynexisSCYX	Share award — · 23,000 shares	Jun 26, 2025
Akebia TherapeuticsAKBA	Share award — · 35,700 shares	Jun 10, 2025

Share awardScynexis

Jun 26, 2025 · SCYX

23,000

Jun 10, 2025 · AKBA

35,700

2 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.